Cargando…
Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
BACKGROUND: Interleukin-6 (IL-6) is commonly highly secreted in the breast cancer (BrCA) microenvironment and implicated in disease development. In this study, we aimed to determine the role of the IL-6/pSTAT3/HIC1 axis in the breast cancer microenvironment, including in cancer-associated fibroblast...
Autores principales: | Sun, Xueqing, Qu, Qing, Lao, Yimin, Zhang, Mi, Yin, Xiaoling, Zhu, Huiqin, Wang, Ying, Yang, Jie, Yi, Jing, Hao, Mingang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891969/ https://www.ncbi.nlm.nih.gov/pubmed/31795965 http://dx.doi.org/10.1186/s12885-019-6333-6 |
Ejemplares similares
-
IFI35 Promotes Renal Cancer Progression by Inhibiting pSTAT1/pSTAT6-Dependent Autophagy
por: Chai, Dafei, et al.
Publicado: (2022) -
Expression of tSTAT3, pSTAT3(727), and pSTAT3
(705) in the epithelial cells of hormone‐naïve prostate cancer
por: Krzyzanowska, Agnieszka, et al.
Publicado: (2019) -
Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway
por: Wang, Xiumin, et al.
Publicado: (2016) -
Small Activating RNA Restores the Activity of the Tumor Suppressor HIC-1 on Breast Cancer
por: Zhao, Feng, et al.
Publicado: (2014) -
Direct targets of pSTAT5 signalling in erythropoiesis
por: Gillinder, Kevin R., et al.
Publicado: (2017)